Clinical Trial Update: KN046 in Subjects With Advanced Squamous Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update for KN046 in subjects with squamous non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• KN046

Snippet

Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Conditions: Squamous Non-small-cell Lung Cancer | Phase 3 | Status: UNKNOWN